Michael Rosenblatt Merck & Co., Inc. (MRK) insider trading activity
Michael Rosenblatt is Exec V-P & Chief Med Officer of Merck & Co., Inc.. Currently has a direct ownership of 41,133 shares of MRK, which is worth approximately $4.85 Million. The most recent transaction as insider was on Feb 22, 2016, when has been sold 7,738 shares (Common Stock) at a price of $50.77 per share, resulting in proceeds of $392,858. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
41.1K
0%
3M change
0%
12M change
Total Value Held
$4.85 Million
Michael Rosenblatt Transaction History
Also insider at
MR
Michael Rosenblatt
Exec V-P & Chief Med Officer
Kenilworth, NJ